arrow
G

George G. Nomikos

university of thessaly
H指数:64
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term safety and tolerability of transdermal cannabidiol gel in children and adolescents with Fragile X syndrome (ZYN2-CL-017): an interim analysis of an ongoing open-label extension study
2025-11-180
OAAI
LONG-TERM SAFETY AND SUSTAINED EFFICACY OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN THE TREATMENT OF IRRITABILITY-RELATED BEHAVIORAL SYMPTOMS IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH FRAGILE X SYNDROME: UPDATE TO OPEN-LABEL EXTENSION STUDY

ZYN002大麻二酚透皮凝胶在治疗脆性X综合征儿童、青少年和年轻成人易怒相关行为症状中的长期安全性和持续有效性:开放标签扩展研究的更新

2024-10-010
PRE
Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3

Apitegromab在2型和3型脊髓性肌萎缩症患者中的安全性和有效性

2024-03-126
OAAI
A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy

新型肌肉生长抑制素抑制剂Apitegromab (SRK-015) 的随机1期安全性,药代动力学和药效学研究: 脊髓性肌萎缩症的潜在治疗

2021-05-0830
OAAI
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
2021-01-0116
OAAI